This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts
PharmacoEconomics - Open Open Access 27 September 2019
-
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
Journal of Hematology & Oncology Open Access 16 April 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Burnett A, Wetzler M, Lowenberg B . Therapeutic advances in acute myeloid leukemia. J Clin Oncol 2011; 29: 487–494.
Sekeres MA . Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives. Haematologica 2008; 93: 1769–1772.
Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453–474.
Bertoli S, Berard E, Huguet F, Huynh A, Tavitian S, Vergez F et al. Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia. Blood 2013; 121: 2618–2626.
van Walraven C, Davis D, Forster AJ, Wells GA . Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol 2004; 57: 672–682.
Østgård L, Nørgaard J, Severinsen M, Friis L, Jensen M, Nielsen O et al. Data quality in the Danish National Acute Leukemia Registry: a hematological data resource. Clin Epidemiol 2013; 5: 335–344.
Østgård L, Nørgaard J, Sengeløv H, Severinsen M, Friis L, Marcher C et alComorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study, March 2014 (under submission).
Frank L . Epidemiology. When an entire country is a cohort. Science 2000; 287: 2398–2399.
Greenland S . Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995; 6: 356–365.
Fisher LD, Lin DY . Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999; 20: 145–157.
Rothmann KJ, Greenland S . Cohort Studies. In: Rothman KJ, Greenland S, Lash TL (eds) Modern Epidemiology 3rd edn Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2008; pp 100–110.
Levesque LE, Hanley JA, Kezouh A, Suissa S . Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 2010; 340: b5087.
Juliusson G . Older patients with acute myeloid leukemia benefit from intensive chemotherapy: an update from the Swedish Acute Leukemia Registry. Clin Lymphoma Myeloma Leuk 2011; 11 (Suppl 1): S54–S59.
Gangatharan SA, Grove CS, P'ng S, O'Reilly J, Joske D, Leahy MF et al. Acute myeloid leukaemia in Western Australia 1991–2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome. Intern Med J 2013; 43: 903–911.
Acknowledgements
This study was supported by research funding from the Danish Cancer Society, The University of Aarhus (Faculty of Health), the AV Lykfeldt’s Foundation, Gr Brogaard and Wife’s Foundation, F Ejner Willumsen’s Grant, Arvid Nilsson’s Foundation and Fraenkel’s Memorial Foundation to LGSØ. None of the funding sources had a role in the design, conduct, analysis or reporting of the study results.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Østgard, L., Nørgaard, J., Sengeløv, H. et al. Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort study. Leukemia 28, 1926–1929 (2014). https://doi.org/10.1038/leu.2014.157
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2014.157
This article is cited by
-
Real-world challenges in the management of acute myeloid leukemia: a single-center experience from North India
Annals of Hematology (2022)
-
Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts
PharmacoEconomics - Open (2020)
-
Analysis of Clinical Profile and Outcome of Tuberculosis in Patients with Acute Leukemia
Indian Journal of Hematology and Blood Transfusion (2018)
-
Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012
Leukemia (2016)
-
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
Journal of Hematology & Oncology (2016)